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Conformational changes and flexibility in T-cell receptor
recognition of peptide–MHC complexes
Kathryn M. ARMSTRONG*, Kurt H. PIEPENBRINK* and Brian M. BAKER*†1

A necessary feature of the immune system, TCR (T-cell receptor)
cross-reactivity has been implicated in numerous autoimmune
pathologies and is an underlying cause of transplant rejection.
Early studies of the interactions of αβ TCRs (T-cell receptors)
with their peptide–MHC ligands suggested that conformational
plasticity in the TCR CDR (complementarity determining region)
loops is a dominant contributor to T-cell cross-reactivity. Since
these initial studies, the database of TCRs whose structures have
been solved both bound and free is now large enough to permit
general conclusions to be drawn about the extent of TCR plasticity
and the types and locations of motion that occur. In the present
paper, we review the conformational differences between free and
bound TCRs, quantifying the structural changes that occur
and discussing their possible roles in specificity and crossreactivity. We show that, rather than undergoing major structural

alterations or ‘folding’ upon binding, the majority of TCR CDR
loops shift by relatively small amounts. The structural changes
that do occur are dominated by hinge-bending motions, with loop
remodelling usually occurring near loop apexes. As predicted
from previous studies, the largest changes are in the hypervariable
CDR3α and CDR3β loops, although in some cases the germlineencoded CDR1α and CDR2α loops shift in magnitudes that
approximate those of the CDR3 loops. Intriguingly, the smallest
shifts are in the germline-encoded loops of the β-chain, consistent
with recent suggestions that the TCR β domain may drive ligand
recognition.

INTRODUCTION

and Rudolph et al. [5]. Yet even since these contributions, the
TCR–pMHC structural database has grown considerably. With
regards to TCR cross-reactivity, the number of TCRs, both bound
and free, for which structural information is available is now
large enough to permit general conclusions to be drawn about
conformational changes in TCR antigen-binding sites and their
roles in receptor specificity and cross-reactivity.
In the present paper, we review the database of TCRs whose
structures have been determined both bound and free, focusing
on molecular flexibility and dynamics. We primarily discuss TCR
CDR loops, initially examining how loop flexibility and dynamics
might influence TCR specificity and cross-reactivity, but also
comparing loop positions in cases where the same receptor is
bound to different ligands. Overall, we conclude that, although
TCR conformational changes do broaden TCR reactivity, with
few exceptions, the underlying motions do not reflect the largescale flexibility which is characteristic of disordered regions;
rather, the motions tend to be rigid-body shifts facilitated mostly
by hinge-bending movements. The largest shifts occur in the
randomly generated CDR3α and CDR3β loops, with the germline
loops typically making relatively minor rigid-body adjustments.
Interestingly, we observe that the germline-encoded CDR1 and
CDR2 loops of the TCR β-chain alter their conformations the least
upon recognition of pMHC, consistent with a role for the β-chain
in driving the recognition of MHC as hypothesized recently [6–8].
Finally, we highlight emerging principles in the basic biophysics
of protein–protein recognition, discussing the similarities and
differences between induced-fit binding and conformational
selection from a pre-existing equilibria, concluding with a call
for more sophisticated experiments capable of fully resolving

αβ TCRs (T-cell receptors) expressed by CD4+ or CD8+ T-cells
are responsible for recognizing antigenic peptides bound and
presented by class I or class II MHC proteins. Recognition of
a pMHC (peptide–MHC) complex by a TCR is required for
the initiation and propagation of a cellular immune response,
as well as the generation and maintenance of the body’s T-cell repertoire. In some regards, TCRs are similar to antibodies. Notably,
TCR antigen-binding sites are composed of multiple CDR (complementarity determining region) loops generated via recombination processes similar to those used in antibody generation.
However, one of the many differences between antibodies and
TCRs is the nature of the ligand recognized. Whereas antibodies
recognize linear or non-linear epitopes of seemingly unlimited
chemical and structural diversity, TCRs recognize a composite
surface consisting of elements of the antigenic peptide as well as
the α-helices of the MHC peptide-binding groove. Thus, unlike
antibodies, the ligand for the TCR consists of both self (the
MHC) and non-self (the peptide) components. TCRs are also
cross-reactive, capable of recognizing multiple peptides bound to
one or more MHC molecules. TCR cross-reactivity is necessary
for T-cell development and maintenance and is crucial given the
fixed size of the T-cell repertoire relative to the vast universe
of potential antigens [1–3]. Moreover, TCR cross-reactivity has
been implicated in numerous autoimmune pathologies and is an
underlying cause of transplant rejection.
The structural and physical properties of TCRs and their complexes with pMHC molecules have been reviewed several times,
with perspectives provided previously by Garcia and Adams [4]

Key words: conformational selection, cross-reactivity, crystal
structure, induced fit, peptide–MHC (pMHC), T-cell receptor
(TCR).

Abbreviations used: CDR, complementarity determining region; MBP, myelin basic protein; pMHC, peptide–MHC; TCR, T-cell receptor.
1
To whom correspondence should be addressed (email brian-baker@nd.edu).
© 2008 The Author(s)

c The Authors Journal compilation 
c 2008 Biochemical Society
The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.

Biochemical Journal

*Department of Chemistry and Biochemistry, 251 Nieuwland Science Hall, University of Notre Dame, Notre Dame, IN 46556, U.S.A, and †Walther Cancer Research Center,
251 Nieuwland Science Hall, University of Notre Dame, Notre Dame, IN 46556, U.S.A.

184
Table 1
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TCR CDR loop shifts identified through comparison of bound/free structures

CDR loop shifts (in Å) tabulated by superimposing the backbones of bound and free TCRs and measuring the maximum difference between equivalent backbone atoms at or near the loop apex. For
both the unligated and bound structures, the PDB code and the resolution in Å (in parentheses) are stated. Loop shifts greater or equal to 1.5 Å were assigned to hinge-bending motions (hb), loop
remodelling (rm) and/or rigid-body framework shifts (rb) by visible inspection. Average shifts are the mean +
− S. D. of each CDR loop shift.
CDR loop shifts
TCR

Unligated structure

pMHC ligand and MHC class

Bound structure

1α

2α

3α

3β

2β

1β

References

1G4∗
2C†

2BNU (1.4)
1TCR (2.5)

LC13
ELS4
JM22
KB5-C20‡
E8§
1934.4
D10
Average shifts

1KGC (1.5)
2NW2 (1.4)
2VLM (2.0)
1KB5 (2.5)
2IAL (1.9)
2Z35 (2.2)
1BWM

NY-ESO9V/HLA-A2 (class I)
SIYR/H2-Kb (class I)
dEV8/H2-Kb (class I)
dEV8/H2-Kbm3 (class I)
QL9/H2-Ld (class I)
EBV/HLA-B8 (class I)
EPLP/HLA-B3508 (class I)
FLU/HLA-A2 (class I)
PKB1/H2-Kb (class I)
TPI/HLA-DR1 (class II)
MBP/I-Au (class II)
CA/I-Ak (class II)

2BNQ (1.7)
1G6R (2.8)
2CKB (3.0)
1MWA (2.4)
2OI9 (2.4)
1MI5 (2.5)
2NX5 (2.7)
1OGA (1.4)
1KJ2 (2.7)
2IAN (2.6)
2PXY (2.2)
1D9K (3.2)

1.6 (hb)
3.7 (hb, rb)
4.6 (hb, rb)
4.4 (hb, rb)
4.5 (hb, rb)
3.4 (hb)
1.5 (hb)
3.4 (rb)
0.7
2.0 (rb)
2.0 (rm)
1.7 (hb)
2.8 +
− 1.4

1.0
1.2
0.9
0.3
0.6
3.6 (rm)
1.0
3.6 (hb, rb)
0.6
2.6 (rb)
1.6 (hb)
2.8 (hb, rb)
1.7 +
− 1.2

2.1 (rm)
5.6 (hb, rm)
6 (hb, rm)
5.5 (hb, rm)
5.5 (hb, rm)
5.8 (hb, rm)
6.1 (hb, rm)
5.6 (hb, rm, rb)
1.6 (hb)
1.6 (hb, rb)
4.3 (hb, rm)
6.5 (hb)
4.7 +
− 1.8

1.5 (hb)
1.7 (rm)
2.3 (hb, rm)
1.3
1.4
3.9 (hb)
1.2
5.0 (hb)
11.4 (hb, rm)
3.4 (hb, rm)
6.6 (hb, rm)
5.7 (rb)
3.8 +
− 3.0

0.5
1.1
1.4
0.9
0.7
0.9
2.0 (hb, rb)
0.8
2.5 (hb, rb)
2.1 (rb)
1.2
1.2
1.3 +
− 0.6

0.6
0.6
0.6
0.6
0.6
0.5
1.2
0.8
2.8 (hb, rb)
1.4
1.9 (rm)
1.5 (hb, rm)
1.1 +
− 0.7

[24]
[14,30]
[13]
[28]
[29]
[27,32]
[26]
[8,31]
[35]
[25]
[23]
[33,34]

∗

The structure of 1G4 bound to the very similar NY-ESO9C/HLA-A2 ligand was not included in the analysis.
†The structure of the high-affinity 2C variant m6 bound to QL9/H-2Ld was not included in the analysis.
‡The unligated structure of the KB5-C20 TCR was crystallized with a Fab bound to the framework region of the Vβ domain.
§The structure of E8 bound to the very similar TPI-T28I/HLA-DR1 ligand was not included in the analysis.
The unligated structure of the D10 TCR was determined via NMR. The co-ordinates used were the best representative conformer of the structural ensemble as identified in the co-ordinate file.

binding mechanisms and characterizing protein conformational
dynamics.
SUMMARY OF CONFORMATIONAL SHIFTS IN TCR CDR LOOPS
OCCURRING UPON BINDING

In the mid-to-late 1990s, binding studies performed with soluble
ectodomains of αβ TCRs and class I or class II pMHC complexes
indicated that TCRs bind pMHC weakly with low association
rates, typically < 105 M−1 · s−1 [9]. Rates of this magnitude are
lower than expected for a geometrically constrained diffusionlimited interaction, normally expected to be near to 106 M−1 · s−1 in
the absence of electrostatic steering forces [10,11]. As slow binding kinetics can result from conformational adjustments required
for binding, Davis and colleagues suggested that the TCR CDR
loops must undergo conformational changes upon recognition of
the ligand [12]. This suggestion was supported by crystallographic
studies of the murine αβ TCR 2C, for which three out of six CDR
loops were shown to display different conformations in the free
and bound states [13,14].
Around the time of the first structural and kinetic observations,
the inherent cross-reactivity of TCRs was becoming increasingly
appreciated [15–17]. This appreciation was highlighted by
Mason’s [1] estimation that any given T-cell is capable of reacting
“productively with approximately 106 different MHC-associated
minimal peptide epitopes”. TCR cross-reactivity fits well with
the observation that receptor binding occurs with conformational
shifts in the CDR loops, as plasticity or adaptability in the binding
interface could broaden the reactivity of any given receptor.
The structures of the 2C TCR both free and bound to pMHC
were followed by the structures of the human αβ TCR A6, first
bound to the native Tax peptide, then to three Tax variants,
all presented by the class I MHC molecule HLA-A2 [18,19].
Differences in the positions of the CDR loops were observed when
the structures were compared, contributing further to the idea
that TCR-binding loops can move upon binding. This study was
followed by thermodynamic experiments indicating that TCRs
recognize a ligand with unfavourable entropy and large negative

heat-capacity changes [20,21], both consistent with a reduction
in protein dynamics or conformational changes occurring upon
binding [22].
Since these initial studies, many additional TCR crystallographic structures have cemented the notion that CDR loops
can adopt different conformations between their bound and free
forms. But how extensive are these changes, and what kind of
motions do they represent? The most helpful information has
come from instances where the structures are available for both
bound and free TCRs: at the present time, including structures
where different pMHC complexes are bound to the same receptor
and excluding structures involving slightly altered peptides, there
are 12 such examples with nine different receptors [7,8,13,14,23–
33]. Table 1 summarizes the conformational differences in CDR
loops seen in these cases, tabulated by reporting the distances
between backbone atoms of the loop apexes when the bound and
free receptors are superimposed. All of the TCRs have at least
one CDR loop that differs in position by 2 Å (1 Å = 0.1 nm) or
more, and all but two have at least one CDR loop that differs in
position by 5 Å or more. There are no distinctions between MHC
class I- or MHC class II-specific TCRs. Notably, in all cases, the
largest shifts are in the randomly generated CDR3α or CDR3β
loops. However, the germline-encoded CDR1 and CDR2 loops
also shift, particularly in the α-chains. Indeed, in the 2C, JM22
and LC13 TCRs, shifts in CDR1α and/or CDR2α are of a similar
magnitude to those in the CDR3 loops.
Further insight is gained by examining the means +
− S.D. of
the loop shifts, also reported in Table 1. While still indicating
that the greatest shifts occur in the CDR3 loops followed
by CDR1α/CDR2α, this analysis also reveals that the shifts
for the germline-encoded loops of the β-chains are smaller
than those of the α-chains (the average shifts for CDR1β and
CDR2β are 1.1 +
− 0.7 Å and 1.3 +
− 0.6 Å respectively, compared
with 2.8 +
− 1.4 Å and 1.7 +
− 1.2 Å for CDR1α and CDR2α
respectively).
The loop shifts summarized in Table 1 are illustrated in Figure 1, which shows the superimposed bound and free TCRs from
the perspective of the pMHC. Through simple visual inspection,
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Figure 1
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Conformational differences in the CDR loops of bound and free TCRs

The view is of superimposed TCRs from the perspective of the MHC peptide-binding groove, with the peptide from the bound structure shown for reference (purple). Yellow and blue represent the
free and bound receptors respectively. For the 2C TCR, only the differences between the free receptor and 2C bound to SIYR/H-2Kb are shown; see Figure 4 for views of loop positions when 2C is
bound to other ligands. The discontinuous segment for CDR3α in the unligated ELS4 TCR reflects missing electron density. The image for the unligated D10 TCR, whose structure was determined
via NMR, was generated using the best representative conformer of the structural ensemble as identified in the co-ordinate file.

the types of loop shift seen in Figure 1 can be placed into three
major classes: (i) loop remodelling facilitated by multiple φ/ψ
bond angle changes, usually near the loop apex, (ii) hingebending motions facilitated by correlated bond changes near
the beginning and end of the loop, and (iii) rigid-body shifts
driven by hinge motions deep within the TCR framework regions

or Vα/Vβ domain shifts. Although some loop shifts fit into
only one class (e.g. CDR3β of JM22 moves solely by hingebending motions), many fit into more than one (e.g. CDR3α
of ELS4 moves by hinge bending and loop remodelling). The
three general classes of CDR loop movements are illustrated in
Figure 2 for LC13 CDR3β (hinge bending), 1G4 CDR3α (loop
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Figure 2 Conformational changes in TCR CDR loops fall into three general classes: hinge-bending movements, loop remodelling or rigid-body movements
originating in the TCR framework region
The three classes are illustrated in (a) by CDR3β of the LC13 TCR (hinge bending), (b) by CDR3α of the 1G4 TCR (loop remodelling) and (c) by CDR3α of the E8 TCR (rigid-body shift). Yellow
and blue represent the free and bound receptors respectively.

remodelling) and E8 CDR2α (rigid-body shift due to framework
shifts).
Each loop shift of 1.5 Å or greater is categorized in Table 1.
Overall, there are 33 instances of loops that move by hingebending motions (with often more than two hinges per loop),
18 instances of loop remodelling and 16 instances of rigid-body
shifts. Loop remodelling occurs in CDR3 loops more than three
times as often as it does in CDR1/2 loops (14 times for CDR3
compared with four times for CDR1/2), illustrating further the
greater plasticity of the randomly generated CDR3 loops. Yet,
even with the higher frequency of loop remodelling, the CDR3
loop shifts are still dominated by hinge bending and rigid-body
shifts: of all the CDR3 loop shifts greater than 3 Å , none of them
is facilitated solely by loop remodelling (even CDR3α of the
ELS4 TCR, which is missing electron density in the centre of
the loop, has clear hinges prior to the region of missing density).
Many loop shifts combine all three motional modes, with the
largest driven primarily by hinge bends, with loop remodelling
at or near the centre of the loop (e.g. CDR3α in LC13 and
CDR3β in JM22). The picture that emerges from the data is that,
with few exceptions, TCR CDR loops do not wholly reorganize
(or fold) upon ligand binding. Rather, motions tend to be block
shifts, occasionally enhanced via small amounts of remodelling.
Small adaptations dominate for the germline-encoded loops, with
the adaptations in Vβ typically less than those in Vα. This picture,
which is unaltered if the multiple results for the 2C TCR are
excluded from the analysis, is consistent with the prediction of
Garcia and Adams [4] that TCR CDR loops are unlikely to be
“easily accommodating limp noodles”.
Recent structural studies of the JM22, 1934.4 and 172.10 TCRs
suggest that the TCR β-chains may play the dominant role in
pMHC recognition [6 –8]. As discussed further below, the results
in Table 1 and Figure 1 are compatible with this suggestion,
evoking a binding mechanism involving rigid-body association
using the β-chain germline loops, with structural adaptations
occurring in CDR3β and/or one or more of the α-chain loops.
Although the results are not shown, there is not a strong
correlation between CDR3 loop length and the magnitude of
structural shift. The sole exception is CDR3β of the KB5-C20
TCR, which, at a length of 13 amino acids, has the largest
structural shift at 11.4 Å [34]. However, the CDR3 loops of the
remaining TCRs, which range from seven to eleven amino acids

for CDR3α and six to nine amino acids for CDR3β, show no
relationship between loop length and structural shift.
Not shown in Figures 1 or 2 are changes in side-chain position coupled to backbone shifts. Usually, changes in side-chain
positions are proportional to the magnitude of backbone shifts,
with shifts larger than 4 Å typically resulting in very large changes
in side-chain positions as a result of reorientations of the Cα–Cβ
bond vectors. This is particularly so for aromatic side chains
which extend far from the peptide backbone. For example, in recognition of the SIYR peptide by the 2C TCR, the 6 Å shift in
CDR3α translates into a 12 Å shift in the side chain of Phe100 at
the apex of the loop, moving it to the periphery of the interface
out of the way of the pMHC [29]. In recognition of the MBP
(myelin basic protein) peptide by the 1934.4 TCR, the 4 Å shift
in CDR3α results in a very similar 10 Å shift in the position of
Tyr100 [8]. As expected, smaller backbone shifts typically translate
into less dramatic changes in side-chain positions. One exception
to this is Tyr95 of CDR3β in the E8 TCR. Despite a moderate loop
shift of 3.4 Å , the Tyr95 hydroxy group moves by nearly 9 Å upon
binding, forming a hydrogen bond with the peptide backbone [24].
Another exception is in the CDR2α of the LC13 TCR: despite a
loop shift of 3.6 Å , the Ser52 hydroxy group moves by 7 Å upon
binding, interacting with the MHC α2 helix [31].

TCR DOMAIN SHIFTS AND BINDING-SITE STRUCTURAL DIVERSITY

Rigid-body shifts between TCR Vα and Vβ domains have been
identified as an additional mechanism in promoting conformational variability in TCR–pMHC interfaces. TCR Vα/Vβ
domain shifts were first identified by Reiser et al. [34] in their characterization of the interaction between the KB5-C20 TCR and H2Kb /pKB1, in which the TCR Vβ domain rotates 8.7◦ relative
to Vα upon binding of pMHC. When the bound and free Vα
domains are superimposed, this rotation contributes approx. 1 Å
to the approx. 3 Å displacements seen in the β-chain CDR loops.
Gagnon et al. [35] identified a similarly sized Vα/Vβ shift in
the A6 TCR upon recognition of the bulky Tax-5K-IBA peptide
presented by HLA-A2. More recently, after identifying domain
rotations in multiple copies of the free 1.D9.B2 TCR, McBeth
et al. [36] performed a rigorous three-dimensional analysis of
the relative orientations of TCR Vα/Vβ domains in available
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TCR–pMHC structures, identifying significant variations in
rotation and pitch.
IMPACT OF TCR LOOP SHIFTS ON THE STRUCTURE AND
CHEMISTRY OF THE INTERFACE

If TCR CDR loop shifts are generally not large-scale reorganizations, folding reactions or disorder-to-order transitions, what
is the impact of the smaller-scale changes usually observed? With
low-molecular-mass antigens, small loop movements can have a
dramatic effect on how an antigen ‘sees’ an incoming antibody.
Yet when the ligand is a large peptide or protein complex contributing 1000 Å 2 or more of surface to the interface, does the
capacity for a few loops and their extending side chains to
move by a few angstroms make a significant difference? The
answer to this question depends on separate but closely related
questions: what are the energetic costs of the structural shifts,
do they alter the structure and chemistry of the antigen-binding
site in a way that influences binding, and to what extent do the
new interactions across the interface compensate for the costs
associated with the loop and side-chain movements? These questions have been considered in numerous studies of protein–protein
interactions, but, unfortunately, although our understanding of the
energetics of rigid-body interactions has grown considerably,
the situation is greatly complicated when the flexibility of one
or more binding partners must be considered. Furthermore, for
most of the results in Table 1, we simply do not know whether
any of the loop motions are readily sampled by free TCRs or
whether they are induced by binding and, if they are induced, we
do not have estimates of the associated energetic penalties. An
exception to this might the D10 TCR, whose unligated structure
was determined using NMR [33]. The 15 lowest energy structures
give some indication about the structural ensemble populated by
the free receptor, and comparison of the various co-ordinate sets
suggests considerable CDR loop mobility: as much as 13 Å for the
apex of CDR3β. However, although the mobility implied in
the D10 structural ensemble is provocative, it is important to keep
in mind that protein flexibility is just one of the factors that can
influence final NMR models, and the range of motion indicated
by an NMR structural ensemble may not directly correlate with
the actual extent of mobility [37].
In contemplating the results shown in Table 1, we must also
keep in mind that the error associated with crystallographic
experiments is exacerbated as the resolution increases. For many
of the interactions in Table 1, the quantitative loop shifts reported
may be pushing the precision of the structural data, as the shifts
represent the differences between two structures, each with their
own accuracy and precision. Furthermore, it remains possible that
the database of TCRs whose structures have been determined
in the unligated state is biased by the inability to crystallize
molecules with large amounts of dynamic disorder.
Given the caveats above, how do the loop motions highlighted
in Table 1 and Figure 1 influence the structure and chemistry
of the antigen-binding sites? A close analysis reveals that, even
when TCR conformational changes are small (as in the case of the
1G4 TCR, for which bound and free structures were both solved
to < 2 Å resolution), the interfaces are altered in a fashion that
should be expected to influence binding. This is demonstrated in
Figure 3, which shows a view of the solvent-accessible surface
area of the antigen-binding sites of the 2C, LC13, E8 and 1G4
TCRs from the view of the peptide, coloured by electrostatic
potential (for the bound structures, electrostatic potentials were
calculated using the co-ordinates of the receptor only). To aid in
interpreting how the TCRs adapt to their ligands, the peptides
are shown in their correct orientation beneath the receptors (even

187

for the unligated forms). In each case, there are clearly visible
differences between the bound and free forms of the TCRs. In the
case of the 1G4, the TCR which is most similar in its bound and
free states, the small 2 Å shift in CDR3α is necessary for opening
the central positively charged pocket juxtaposed between the Vα
and Vβ domains.
INFLUENCE OF CDR CONFORMATIONAL CHANGES ON TCR
SPECIFICITY AND CROSS-REACTIVITY

Despite their occurrence, questions remain about the role of TCR
conformational changes in binding, particularly in specificity
and cross-reactivity. Do CDR loop movements broaden TCR
reactivity as originally supposed? Several TCR–pMHC structures
with the 2C, BM3.3 and A6 TCRs have allowed this question
to be addressed. For the 2C TCR, structures are available for
the receptor bound to four different pMHC ligands: dEV8/H2Kb [13], dEV8/H-2Kbm3 [27], SIYR/H-2Kb [29] and QL9/
H-2Ld [28]. These ligands present a range of different structures
and chemistries to the TCRs. In the case of the dEV8 peptide,
H-2Kb and H-2Kbm3 differ by MHC amino acid substitutions that
alter peptide anchoring, causing distortions in the C-terminal end
of the dEV8 peptide [27]. For the other 2C structures, although
the SIYR and dEV8 peptides share similar charge and aromatic
features (SIYRYYGL and EQYKFYSV respectively), the QL9
peptide (QLSPFPFDL) differs substantially from the SIYR and
dEV8 peptides. The conformations of the loops for the five 2C
TCR structures (one free and four bound) are shown in Figure 4(A). Interestingly, despite many different local interactions
in the interfaces, the various loops in the dEV8/Kb , dEV8/Kbm3 ,
SIYR/Kb and QL9/Ld structures are all in similar conformations, each deviating by approximately the same amount from the
unligated 2C structure. The differences in the QL9/Ld structure
are slightly more dramatic, particularly for CDR3α, which is
‘bent’ more towards the peptide C-terminus than in the other
three bound structures, and CDR1α, which deviates less from its
unligated conformation. Perhaps most interestingly, the 2C TCR
assumes a more diagonal binding orientation on QL9/Ld than
on dEV8/Kb or SIYR/Kb , placing the germline-encoded loops
over different regions of the MHC α1/α2 helices [28] [this is
apparent in Figure 4(A) by the different orientations of the dEV8
and QL9 peptides]. Yet the overall conformations of the various
germline loops remain unperturbed, reinforcing the idea that the
CDR1 and CDR2 loops undergo relatively minor conformational
changes upon recognition of pMHC, and, when they do move, the
movements tend to be dominated by rigid-body shifts. Overall,
the 2C results indicate that TCR cross-reactivity need not be
driven by dramatic alterations in the TCR-binding site, the
existence of different interatomic contacts within the interface
notwithstanding.
For the BM3.3 TCR, although no structure is available for the
free receptor, structures are known for the receptor bound to three
different pMHC ligands: pBM1/H-2Kb [38], pBM8/H-2Kbm8 [39]
and VSV8/H-2Kb [40]. Again, these ligands differ considerably
in both sequence and chemistry: the amino acid sequences are
INFDFNTI for pBM1, RGYVYQGL for VSV8 and SQYYYNSL
for pBM8. The positions of the loops in the three BM3.3 TCR
structures are shown in Figure 4(B). The conformation of CDR3α
varies dramatically between the three structures, differing by as
much as 6.6 Å , with the changes driven by hinge bending and
loop remodelling. The conformation of CDR3β is the same in the
pBM1 and VSV8 structures, but is shifted by as much as 4.4 Å in
the pBM8 structure as a result of a large wrinkle in the centre of
the loop. The positions and conformations of the various germline
loops are largely unaltered, with the exception being CDR2α in
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Figure 3

K. M. Armstrong, K. H. Piepenbrink and B. M. Baker

Stereo image of the solvent-accessible surfaces of the 2C, LC13, E8 and 1G4 TCRs from the view of the MHC peptide-binding domains

Colouring is by electrostatic potential, from − 25 k T (red) to + 25 k T (blue). For each TCR, the top view is of the unligated TCR superimposed on to the bound receptor, whereas the bottom view
is of the ligated TCR. Peptides are shown in both the bound and unbound views for orientation. In each case, there are clear differences in structure and electrostatics between the free and bound
receptors. Electrostatic potentials were calculated using the program DelPhi [101].

the pBM8 structure, which is displaced by approx. 2 Å owing to
hinge bends at the beginning and end of the loop. The affinity
of BM3.3 for the pBM8 ligand is substantially weaker than for
the pBM1 ligand [39], possibly as a result of the reorganization
of CDR3β and displacement of CDR2α, but also possibly from

the different interactions present within the interface. Unlike the
2C TCR, BM3.3 binds the three pMHC complexes in the same
diagonal orientation.
Lastly, although no structure is available for the free receptor,
there are five structures of the A6 TCR bound to peptides
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Biophysical for TCR–pMHC interactions with structures available in the free and bound states

1 kcal ≈ 4.184 kJ. N/A, not applicable.

TCR–pMHC interaction

Maximum
loop
shift (Å)∗

Affinity (μM)†

1G4–NY-ESO9V/HLA-A2
2C–SIYR/H2-Kb
2C–dEV8/H2-Kb
2C–dEV8/H2-Kbm3
2C–QL9/H2-Ld
1934.4–MBP/I-Au
LC13–EBV/HLA-B8
JM22–FLU/HLA-A2

2.1 (3α)
5.6 (3α)
6.0 (3α)
5.5 (3α)
5.5 (3α)
6.6 (3β)
5.8 (3α)
5.6 (3α)

5.7
32
84
56
3.9
31
8.1
6.6

k on (× 104 M−1 · s−1 )†

S ◦
(cal/mol/K)†

C p experimental/predicted
assuming rigid body (cal/mol/K)‡

1.2
0.2
0.2
0.09
0.6
0.5
N/A
3.0

N/A
−4
− 54
N/A
12
− 32
14
− 50

N/A
− 1100/− 260
− 1100/− 270
N/A
N/A
− 1250/− 230
− 620/− 270
− 640/− 250

SASA buried in TCR transition
from unbound to bound
conformation (Å2 )§

Predicted C p for TCR
structural transition
(cal/mol/K)

N/A

N/A
− 95
− 28
N/A
N/A
− 124
− 40
+ 69

60 apolar, − 262 polar
73 apolar, 16 apolar
N/A
N/A
127 apolar, − 255 polar
143 apolar, 81 polar
− 107 apolar, 80 polar

∗

Maximum loop shift from Table 1, with the shifting loop in parentheses.
†Reported affinity, on-rate and enthalpy change at 25 ◦C.
‡Experimental heat-capacity change determined by van ’t Hoff analysis, followed by the value predicted from the structure of the complex assuming a rigid-body interaction.
§Solvent-accessible surface area buried upon transition from the unligated TCR conformation to the conformation found in the bound state, calculated using co-ordinates for TCR variable domains
only. Negative values reflect exposure, rather than burial, of additional surface area. Surface-area calculations performed with naccess [100], using a probe radius of 1.4 Å and a slice width of 0.05 Å .
Predicted heat-capacity change for the unbound-to-bound structural transition in the TCR, calculated using empirical relationships between changes in solvent-accessible surface area and heat
capacity [22].

presented by HLA-A2: the native Tax peptide and four single
amino acid variants [18,19,35]. Three of the altered peptides
result in large alterations in the interface: the Y8A variant
removes a bulky tyrosine side chain, the V7R variant replaces
a hydrophobic valine residue with a large positively charged
arginine residue, and the Y5K-IBA variant replaces the central
tyrosine residue with a bulkier and more flexible hapten. The
positions of the loops in the five A6 TCR structures are shown in
Figure 4(C). Structural variation is seen mostly in CDR3β, which
moves by an amount that correlates directly with the size of the
perturbation in the interface, culminating in a 5.5 Å shift with
the Y5K-IBA peptide. As with the BM3.3 TCR, the affinity of the
A6 TCR weakens with greater shifts in CDR3β (from 1 μM with
native Tax to 7 μM with V7R and > 160 μM with Y5K-IBA), but,
as noted above, we cannot easily separate the energy associated
with the loop shift from other structural and chemical changes in
the interface.
BIOPHYSICAL CORRELATES WITH CONFORMATIONAL CHANGES
AND DYNAMICS

As noted above, early evidence for CDR loop mobility in TCRs
came from kinetic and thermodynamic measurements of TCR–
pMHC interactions. Although any one set of results is useful in
examining a particular interaction, with the multiple bound/free
TCR structures now available, can quantitative or predictive
relationships be drawn between the aggregated biophysical and
structural data?
Unfortunately, equivalent binding data are not available for all
of the TCR–pMHC interactions for which both bound and free
TCR structures are available. The results that are available are
listed in Table 2. Notably, all of the interactions tabulated have
association rates of less than 105 M−1 · s−1 [8,20,23,29,41,42],
less than the rate of nearly 106 M−1 · s−1 expected for a rigidbody interaction in the absence of electrostatic steering [10,11].
As mentioned above, this is consistent with the structural
differences that are observed between bound and free receptors:
if conformational changes need to occur for binding, then binding
will be slowed by an amount proportional to the rate at which
these changes proceed. However, there is no correlation between
the extent of loop shifts and association rate, nor is there any
correlation with affinity. Neither of these findings is surprising,

as factors other than conformational changes and their associated
exchange rates will influence binding kinetics and affinity.
Unfavourable binding entropy changes have also been used to
support the presence of conformational changes (or reductions in
flexibility) occurring upon TCR recognition of pMHC. The first
several TCR–pMHC interactions studied thermodynamically all
bound with unfavourable entropy changes at 25 ◦C [20,43,44],
and, for a brief period, unfavourable binding entropy changes
were presumed to serve as a ‘thermodynamic signature’ for TCR
binding. Subsequently, however, several TCRs were shown to bind
with favourable entropy changes [28,39,45–48], demonstrating
that there is no clear entropic signature for TCR recognition of
pMHC [49]. Indeed, the interactions shown in Table 2 include
some that proceed with favourable and some that proceed with
unfavourable entropy changes, yet all involve similarly large
changes in CDR loop positions. This result is also not surprising,
as conformational dynamics are only one of many contributors to
binding entropy changes (others include changes in solvation of
polar and apolar surfaces and water/ion release/incorporation).
As every TCR–pMHC interface in Table 2 is different, it is
not unexpected that the various contributions are present to
different extents, yielding positive or negative entropy changes
independently of whether or not reductions in protein flexibility
occur upon binding.
Changes in TCR–pMHC binding heat capacity (Cp ) have
been used in a number of cases as supporting evidence for conformational differences between bound and free TCRs [21,41].
Such evidence stems from the relationship between heat capacity
and the hydration of protein surface: changes in hydration that
occur upon protein binding give rise to changes in heat capacity
[50]. Empirical relationships between polar and apolar solventaccessible surface area are frequently used to predict Cp values
from the structures of protein–protein complexes [22,51], with the
differences between predicted and experimental values usually
attributed to conformational differences between bound and free
proteins, i.e. if treating the complex as a rigid-body interaction
does not correctly predict Cp , the interaction must not be rigid
body.
Experimentally determined heat-capacity changes (Cp )
are available for five of the interactions listed in Table 2
[7,20,41,43,46]. In each case, the experimental Cp was determined by van ’t Hoff analysis (measurements of affinity as a
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Figure 4

K. M. Armstrong, K. H. Piepenbrink and B. M. Baker

Stereo image showing different CDR loop positions when the same TCR is bound to different pMHC ligands

Orientation and TCR superimposition is through the MHC peptide-binding groove as in Figure 1. (a) View of the CDR loops of the 2C TCR free (yellow) and bound to dEV8/H-2Kb (blue), dEV8/H-2Kbm3
(cyan), SIYR/H-2Kb (green) and QL9/H-2Ld (grey). The two peptides shown reflect the more orthogonal docking angle of the 2C TCR on the QL9 compared with the dEV8/SIYR ligands. (b) View of
the CDR loops of the BM3.3 TCR bound to pBM1/H-2Kb (blue), pBM8/H-2Kb (green) and VSV/H-2Kb (grey). (c) View of the CDR loops of the A6 TCR bound to Tax/HLA-A2 (blue), Tax-P6A/HLA-A2
(green), Tax-Y8A/HLA-A2 (cyan), Tax-V7R/HLA-A (grey) and Tax-5K-IBA/HLA-A2 (red). An interactive three-dimensional version of this Figure can be found at http://www.BiochemJ.org/bj/415/0183/
bj4150183add.htm.

function of temperature), and each is significantly more negative
than the Cp predicted by treating the interaction as rigid body,
consistent with the existence of structural differences between
bound and free receptors. Yet do the actual structural differences

between the bound and free receptors account for the deviations between experimental and predicted Cp values? The
question is pertinent, as Cp values are traditionally difficult
to measure via van ’t Hoff analysis, particularly for interactions
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with weak to moderate affinities [52]. Notably, some of the Cp
values in Table 2 approach or exceed heat-capacity changes for
the unfolding of small proteins (for an example, see [53]).
To address this question, for each of the interactions with
Cp measurements available, Table 2 also lists the changes in
polar and apolar solvent-accessible surface area associated with
TCR movement from the unligated to the ligated conformation.
These values were calculated using the co-ordinates of the
unligated TCR variable domains and the co-ordinates of the bound
TCR variable domains extracted from the complex. Also shown
is the predicted Cp for this transition, calculated using the
same empirical relationships used to estimate the binding Cp
(this value has been referred to in previous publications as the
‘conformational Cp ’). In no case does the structural transition
from the unligated to the ligated conformation account for the
discrepancies between experimental and predicted binding heatcapacity changes, as the changes in the solvent-accessible surface
area are simply too small, and the ‘conformational Cp ’ values
never reach more than 10 % of the experimental value. This result
is entirely consistent with the results in Table 1, showing that the
overall magnitude of CDR loop conformational changes occurring
upon TCR binding is relatively small. The conclusion from this
analysis is that, although TCR–pMHC binding heat-capacity
changes are suggestive of conformational differences between
free and bound TCRs, they do not quantitatively report on these
structural differences. In many cases, the discrepancy is likely to
be the result of experimental difficulties in measuring accurate
heat-capacity changes for weak protein–protein interactions [52].
CONFORMATIONAL CHANGES OCCURRING UPON TCR–pMHC
BINDING: INDUCED FIT OR CONFORMATIONAL SELECTION FROM A
PRE-EXISTING EQUILIBRIUM?

The structural results indicate that, although in most cases they are
not dramatic reorganizations, conformational shifts do facilitate
TCR recognition of pMHC ligands and contribute to TCR crossreactivity. The largest conformational shifts tend to be in the
CDR3 loops, with smaller rigid-body shifts occurring in the germline-encoded CDR1/CDR2 loops. But what is the origin of the
underlying motions? Are they induced upon binding or do they
reflect pre-existing equilibria, where binding occurs only to a
compatible conformation present in a larger structural ensemble?
The differences between these two modes of recognition are illustrated in Figure 5. The extent to which TCRs use one or both
of these mechanisms and whether they arise due to biological or
chemical/structural necessity has implications for the molecularrecognition properties of TCRs, and, by extension, the nature of
T-cell specificity and cross-reactivity.
Induced-fit interactions

The notion of induced-fit conformational changes in protein–
ligand interactions began with Koshland’s [54] extension of
the ‘lock and key’ model for enzyme–substrate interactions.
Accordingly, the adaptability of substrates and active-site side
chains allows for the best energetic fit within enzyme active sites;
the same logic is implied when induced-fit motions are used to
describe larger protein–protein interactions. A key requirement
for induced-fit binding is an initial ‘loose’ contact between the two
molecules, followed by structural adaptations to form a higheraffinity complex. If the crystallographically observed TCR conformational changes occurring upon binding do represent
induced-fit motions, the requisite weak initial contact may provide
a mechanism for TCR ‘scanning’ of different peptides, as
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originally proposed by Boniface et al. [21]. In this model, initial
weak binding to MHC molecules would allow higher-affinity
binding only to those ligands to which the best fit could be
obtained before the encounter complex dissociates. Implied in this
model is a physical ‘bias’ of TCRs towards the peptide-binding
domains of MHC molecules. A bias towards TCR recognition
of MHC could have resulted from the co-evolution of immune
receptor gene segments and MHC molecules, as suggested by
Jerne [55], and more recently discussed by Kim et al. [56].
Evidence for an inherent bias for TCR recognition of MHC
was presented in the influential work of Zerrahn et al. [57],
who characterized the MHC reactivity of the T-cell repertoire
prior to positive and negative selection and concluded that TCRs
are inherently MHC reactive. Their results built on work from
Gascoigne and colleagues, who demonstrated a role for germlineencoded CDR loops in directing restriction towards class I or class
II MHC [58]. This was recently followed by data from Kappler
and colleagues, who found that, after relaxing negative selection
in a mouse model, the resultant T-cell repertoire was substantially
more cross-reactive than normal [59]. Biophysical evidence for
biased TCR recognition of MHC has also been presented: using
φ analysis [60], and Wu et al. [61] showed that many amino
acid substitutions in the MHC molecule weakened receptor
binding by lowering association rates, whereas mutations in the
peptide weakened binding by increasing dissociation rates. The results were interpreted as resulting from a ‘two-step’ binding
mechanism: an initial TCR contact to the MHC, followed by
induced-fit adjustments as the receptor ‘settled down’ on the
peptide. More recent biophysical evidence in support of this model
has come from the rapid kinetic measurements of Gakamsky
et al. [48], who found that a TCR specific for the CMV pp65
peptide presented by HLA-A2 bound with a kinetic mechanism
consistent with an induced-fit reaction. Finally, recent structural
studies of the JM22, 1934.4 and 172.10 TCRs suggest that the
TCR β-chains may play the dominant role in pMHC recognition
[7,8]. The results in Table 1 showing that the germline-encoded
CDR1β and CDR2β loops which shift the least upon binding
pMHC are compatible with this suggestion, evoking a binding mechanism involving rigid-body association using the β-chain
germline loops, with structural adaptations occurring in CDR3β
and/or one or more of the α-chain loops.
Undoubtedly, the presence of induced-fit motions coupled with
an inherent TCR bias for recognition of MHCs provides an attractive way to achieve TCR cross-reactivity. Although sometimes
controversial owing to the difficulty of distinguishing between
induced-fit and pre-existing conformational equilibria [62,63],
the presence of induced-fit motions has been firmly established in
other systems (for a review, see [64]). Experimental and theoretical investigations have begun to elucidate what initial ‘loose’
encounter complexes could look like [65,66]. Of particular interest
is the use of paramagnetic relaxation measurements in elucidating
these structures. Tang et al. [65] recently used this approach to
characterize the transient interaction between enzyme I and the
phosphocarrier protein HPr, showing that HPr can initially bind
over a large portion of the surface of enzyme I, followed by electrostatically driven diffusion into the high-affinity-binding site.
Although this interaction is technically not an ‘induced-fit’
binding reaction, one could envision a more refined mechanism
for TCR recognition of pMHC, where the initial binding and
subsequent isomerization of the TCR is limited to the ‘business
ends’ of the TCR and MHC.
Despite the appeal of TCR conformational shifts resulting from
induced-fit motions occurring upon binding, the corollary of a
transient TCR–MHC association arising from the co-evolution of
TCR and MHC genes has been difficult to establish. Mutagenesis
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Figure 5

K. M. Armstrong, K. H. Piepenbrink and B. M. Baker

Schematic diagrams indicating three possible TCR–pMHC binding mechanisms

The left-hand side of each panel illustrates protein association, whereas the right-hand side shows traditional free-energy diagrams showing energy as a function of reaction progress. (a) Rigid-body
docking, where the structures of the TCR and pMHC are identical in the bound and free states. (b) Induced–fit binding, where a loose intermediate energy complex ([TCR-pMHC]∗ ) is initially formed,
followed by rearrangements in the TCR giving rise to the final lowest-energy-bound state. (c) Conformational selection from a pre-existing equilibrium, in which the free TCR samples multiple
conformations (two are illustrated here), with only one being binding competent. As shown, binding to the competent TCR conformation follows a rigid-body mechanism, although, as discussed in
the text, the association phase could also follow an induced-fit mechanism.
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experiments have not identified binding hot spots that are well
conserved across TCR–pMHC interactions [67,68]. The ‘twostep’ binding model of Wu et al. [61] as originally formulated has
been questioned both biophysically and structurally [40,69,70].
Structures of TCR–pMHC complexes have not shown conserved
contacts that could mediate an MHC bias, although structures
of different receptors sharing common variable domains suggest
types of interaction that may be conserved between particular
gene segment–MHC pairs [8,71], and, as noted above, recent
results are compatible with the germline β-chain loops driving
the initial pMHC contact [7]. Finally, Buslepp et al. [72] have
suggested that an inherent bias towards the recognition of MHC
is imparted on the T-cell repertoire not by the co-evolution
of TCR and MHC genes, but by the need for co-receptor
during thymic selection. Thus, although induced-fit motions may
characterize many TCR–pMHC interactions, the extent to which
T-cells take advantage of this for ‘scanning’ peptides still remains
unclear.
Complicating the role of induced fit in TCR recognition of
pMHC are observations that peptides occasionally alter their conformations upon TCR binding. This has been seen most
dramatically for the extensively bulged EPLP (endorphin-like
peptide) presented by HLA-B35, which, as a 13-mer, bulges up
and above the plane of the peptide-binding groove. Binding of
the ELS4 TCR dramatically ‘squishes’ the peptide backbone as
described by Tynan et al. [25], with a large shift of 5 Å occurring
in the centre of the peptide. Smaller backbone shifts in the range
2–3 Å have been seen upon TCR binding to the Tax and NYESO peptides presented by HLA-A2 [18,23,73–75] and the dEV8
peptide presented by H-2Kb and H-2Kbm8 [13,27]. The α-helices
flanking the peptide-binding groove can also shift upon TCR
binding, as seen in the recognition of pBM8/H-2Kbm8 (class I
MHC) by the BM3.3 TCR [39,76] and MBP/HLA-DR2a (class
II MHC) by the 3A6 TCR [77], where, in both cases, rigid-body
shifts of approx. 1 Å are distributed across both the α1 and α2
helices. Overall, most of the changes in pMHC are small, but they
are not much smaller than the magnitude of changes seen in the
TCR CDR loops. Results such as these highlight the danger, in
the absence of supporting structures, of interpreting TCR–pMHC
biophysical data in terms of induced-fit conformational changes
occurring only within the TCR CDR loops.
Conformational selection from a pre-existing equilibrium

An alternative mechanism for achieving the conformational
changes observed in TCR–pMHC interactions is selection from
a pre-existing conformational equilibrium. This mechanism
is related to the energy landscape treatment of protein
conformational dynamics [78], which accounts for the intrinsic
flexibility of proteins and how the free energies of different
structural states dictate the extent to which they are populated.
Although commonly used in discussions of protein folding,
energy landscapes are also applicable to protein binding,
particularly when conformational changes or alterations in
dynamics are involved [79–82]. Holler and Kranz [83] discussed
how pre-existing equilibria could promote TCR cross-reactivity
in their ‘conformer’ model of TCR recognition of pMHC.
Briefly, different conformers (or structural substates) could
recognize different pMHC ligands, with the potential for each
conformer to have different degrees of fine specificity. TCR
cross-reactivity would then be driven not only by the intrinsic
affinity of a conformer for a given pMHC, but also by the
relative populations of substates within the overall structural
ensemble. In TCRs, the conformational ensemble would represent
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alternative loop configurations (based on the results in Table 1,
mostly limited to the CDR3 loops) and possibly different Vα/Vβ
orientations.
Although evidence for pre-existing conformational equilibria in
TCR CDR loops as a means to promote T-cell cross-reactivity has
not yet been presented, this mechanism has been demonstrated
in antibodies. In their classic paper, Foote and Milstein [84]
identified antibodies to the hapten 2-phenyl-5-oxazolone that
bound with complex kinetics best described not by an inducedfit mechanism, but by a mechanism in which the antibodies
populated multiple conformations in the unbound state, of which
only a subset was binding competent. This work built on earlier
studies by Lancet and Pecht [85], and was related to the hypothesis
for antibody cross-reactivity initially formulated by Linus Pauling
in 1940 [86]. However, the model was not widely accepted until
2003, when Tawfik and colleagues showed that the antibody
SPE7 uses this mechanism to cross-react with the hapten 2-nitro4-iodophenol and the protein Trx-Shear3 [87,88]. Key to the
acceptance of the SPE7 results was the availability of not only
rapid kinetic data consistent with a pre-existing conformational
equilibrium, but also crystallographic structures of the bound and
free antibody, demonstrating that conformations seen in different
bound states were sampled in the unligated antibody.
The discussion of pre-existing conformational equilibrium
compared with induced fit in protein binding has a parallel in
allostery, in which a protein adopts a different functional (and
thus structural) state in response to the binding of an allosteric
effector. Although the traditional explanation has been one of
induced fit, the notion of pre-existing conformational equilibria as
an explanatory mechanism for protein allostery has been gaining
ground [89,90]. For example, the NtrC (nitrogen regulatory
protein C) signalling protein exists in two conformational states
depending on its phosphorylation state, yet NMR studies indicate
that it samples the phosphorylated conformation even when
unphosphorylated [91]. The more traditional view of allostery has
been questioned further with observations that allostery can result
purely from dynamical changes: Popovych et al. [92] recently
showed that the binding of one molecule of cAMP to the catabolic
activator protein changed the dynamics of the protein but not the
average structure, strongly influencing the affinity of a second
molecule of cAMP. Similar discussions of induced fit compared
with conformational dynamics have been ongoing in the field of
enzyme catalysis, in which movements necessary for catalysis
are not seen as being induced by substrate binding, but instead
as reflecting an existing flexibility within an active site (for an
example, see [93]).
One issue with pre-existing conformational equilibria in TCR
cross-reactivity concerns the relative populations of differing
conformations. If a conformation capable of recognizing a specific
ligand is only populated a fraction of the time, unless that
conformation has a high intrinsic affinity for the ligand, the overall
binding affinity will be very weak, as the effective concentration
of binding-competent receptor is reduced. Yet, by and large,
crystallographic structures of TCR–pMHC interfaces do not have
hallmarks of high-affinity complexes: the interfaces tend to be
relatively flat, with poor packing, suboptimal surface complementarity and buried water molecules [5]. Although quantitative
predictions of binding affinity from structure are notoriously
inaccurate, in general, the TCR–pMHC complexes whose structures have been solved are consistent with the weak to moderate
affinities that characterize them. We might conclude from this that
if unligated TCR CDR loops do sample conformational states
that promote cross-reactivity, the different structural substates
sampled will be likely to be of similar energies (and thus populations), as otherwise the large energetic penalties for shifting
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equilibria towards minor poorly populated states would need to
be compensated by extremely well optimized protein–protein
interfaces, in contrast with what is seen in most TCR–pMHC
structures. Consequently, TCR structural ensembles are not likely
to be described by large amounts of disorder. Rather, the conformational ensembles should be expected to be dominated by local
backbone/side-chain dynamics or block shifts [4], as is observed
in the structural results summarized in Table 1 and Figure 1.
Consistent with this conclusion, of the nine structures of unligated
TCRs currently available, only two (ELS4 and 1.D9.B2) have
missing electron density, suggesting the dynamic disorder of a
CDR loop [25,36]. An important caveat to this conclusion is that
the database of unligated TCR structures may be biased by those
that are crystallizable, as discussed above.
As noted above, peptides and MHC molecules can undergo
conformational changes upon TCR recognition, and the discussion of a pre-existing conformational equilibria applies equally
to the pMHC complex. Certainly, cases where the peptide has
been shown to be disordered or adopt multiple structures in
the MHC-binding groove are candidates for peptide pre-existing
equilibria having influence on receptor recognition [35,94–97].
However, if both the receptor and the ligand populate broad
conformational ensembles, statistically it seems less probable that
a TCR–pMHC complex would assemble at a reasonable rate if
both molecules need to shift into a binding competent conformation.
Finally, it is possible, if not likely, that different TCRs and
pMHC complexes interact via a combination of induced fit
and conformational selection in ways that are ultimately dictated
by the structure, chemistry and dynamics of each component.
Combinations of these binding modes have been seen in other
protein–ligand interactions, most notably in work with the SPE7
antibody [98]. Further evidence for such a combination comes
from the computational studies of Grunberg et al. [99], who
studied 17 protein–protein interactions and elegantly combined
conformational selection and induced fit into a more general
model for protein–protein recognition. In other computational
studies, regions of proteins that undergo induced-fit motions
have been shown to possess high intrinsic flexibility [62,63],
blurring the distinction between induced fit and conformational
equilibrium.
However, the concept that, biophysically, every TCR–pMHC
interaction is different must be reconciled with the evidence for
a TCR bias towards MHC. The possibility of germline-encoded
β-chains driving initial TCR binding followed by conformational
section from a limited ensemble or moderate induced fit elsewhere
is an attractive means to achieve this reconciliation. What is
needed to fully address these issues are detailed binding investigations that go beyond structural studies and the traditional
surface plasmon resonance experiments commonly performed
in studies of TCR–pMHC interactions. Attractive experiments
include solution kinetic measurements capable of identifying
induced fit and conformational selection (e.g. [48]), as well as
studies of the intrinsic flexibility of TCR CDR loops and peptides bound to MHC molecules (e.g. [33,100]). Correlation of the
resulting data with loop and peptide sequences and the expanding
database of structural and mutational studies should shed further
light on how TCRs use conformational dynamics to achieve their
remarkable molecular recognition properties.
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